糖尿病视网膜病变的治疗和传递系统的最新进展
Zhiyi Wang1, Ningzhi Zhang1, Pei Lin1
1Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Frontiers in endocrinology
|March 1, 2024
概括
糖尿病视网膜病变 (DR) 的治疗方法有限,但针对其神经血管并发症的新疗法显示出希望. 纳米技术为更好的糖尿病视网膜病变管理和未来研究提供了改进的药物输送.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病视网膜病变 (DR) 是导致失明的主要原因,源于糖尿病.
- 病理生理学涉及神经退行,炎症和氧化应激.
- 目前的DR治疗有局限性和副作用.
研究的目的:
- 审查DR病理生理学,当前的治疗方法和药物输送方法.
- 讨论新的治疗点和纳米技术的潜力.
- 为未来的DR研究提供基础.
主要方法:
- 对目前对DR的病理生理学理解的文献综述.
- 对DR的现有和新兴治疗策略的分析.
- 基于纳米技术的药物输送系统对DR的评估.
主要成果:
- 像阿尔多缩酶抑制剂这样的新型药物在延迟DR方面表现出有效性.
- 基于纳米技术的药物输送可以克服溶解性和透性差等问题.
- 正在确定DR治疗的有前途的治疗点.
结论:
- 现有的DR治疗方法有局限性,需要新的方法.
- 新兴疗法和先进的药物输送系统提供了巨大的潜力.
- 对DR病原和治疗的持续研究至关重要.
更多相关视频
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
7.8K
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
13.2K
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
01:27Open Angle Glaucoma: Treatment
448
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
448